EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Kromek Group PLC (KMK) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of Kromek Group PLC £0.13, price £0.07, upside +105.1%, quality 68 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Technology · GB · ISIN GB00BD7V5D43

KG Thin data Sep 23, 2026

Kromek Group PLC

KMK · LSE

Clearly undervaluedStrong Fair Value upside, but quality is only moderate.

✓Fair value £0.1333 · Strongly undervalued (+105%)
✓Quality 68/100
✓Healthy Growth (revenue 5y +15.1 %/yr)
✓Highly profitable · 33.0% net margin (TTM)
✓Low debt · generates free cash flow
✓Ranks above peers (13/13)
✓Wide moat 80/100
!Insider activity 40/100
!Evidence only low, so the estimate is less certain
Watch Kromek Group PLC for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

£0.2100 £0.0325 Fair Value £0.1333 Jul 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.

How to read this chart

60‑month range £0.0325 – £0.2100 · fair‑value band £0.1008 – £0.1658 · the £0.0650 price screens below the £0.1333 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Sep 23, 2026.

Follow Kromek Group in your weekly email

Every Wednesday you see whether Kromek Group is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and bio-detection technology solutions for the advanced imaging, CBRN detection, and biological threat detection markets.

Show more

Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and bio-detection technology solutions for the advanced imaging, CBRN detection, and biological threat detection markets. It offers civil nuclear radiation detection products, which include gamma radiation and neutron detectors, high-specification, high-resolution devices, components, and software for nuclear detection problems, as well as offers a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology for gamma-ray and neutron detection. The company also provides advanced imaging products, including CZT gamma detectors for SPECT imaging, CZT bone mineral densitometry detectors, D-Matrix gamma ray imager, and photon-counting spectral CT systems. In addition, it offers products and components for the security and defence markets, including UAV radiation mapping drones, alpha beta probes, radiation detectors, gamma and neutron detectors, D5 RIID, backpack with radiation detection, static node, tactical deployment detector charging station, and vehicle mounted radiation detector, as well as a range of gamma spectroscopy software that enables specialized analysis of samples. Further, the company provides CZT imaging research development platforms, such as the DMatrix and the EV3500 scalable x-ray CZT linear array for laboratory and research imaging; and engages in the scientific research and development activities. It sells its products through distributors, OEMs, and direct sales. The company has operations in the United Kingdom, North America, Asia, Europe, and internationally. The company was founded in 2003 and is headquartered in Sedgefield, the United Kingdom.

Stock analysis

Kromek Group PLC (KMK) currently trades at £0.0650, while our model-based Fair Value estimate is £0.1333, implying the stock looks roughly 51.2% undervalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of £0.2900 per share, and 20 of the 24 models we run sit above the £0.0650 price.

Bear case: the Asset-Based group reads lowest at £0.0500, and 4 of the 24 models stay below the price. Evidence for this calculation is low.

Scenario range: £0.1008 (bear) to £0.1658 (bull), the price of £0.0650 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 68/100 (solid quality), in the Technology sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Kromek Group PLC reported revenue of 26.5M GBX in FY2025 versus 10.4M GBX in FY2021, a compound +26.5%/yr. Reported net income was 3.8M GBX in FY2025.

Key figures

Market cap 53.1M GBX · P/E ratio 3.3 · P/S ratio 0.46 · EPS (TTM) £0.0200 · Net margin 14.2% · Return on equity 25.1% · Return on assets (EBIT) −4.2% · Operating margin 21.3%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).

What moves the price

The share trades about 48% below its 52-week high and 7% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Technology peers we cover trades at −34% fair-value upside, at 105%, KMK screens cheaper than that median.

Fair Value models

Bear £0.1008 Fair Value £0.1333 Bull £0.1658
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 12 months old). Earnings retained since then (£0.0200 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF £0.2800 £0.4400 £0.8000 77
Growth DCF £0.2700 £0.4600 £0.7500 76
Owner Earnings £0.1600 £0.2900 £0.5100 74
All 24 models by family
DCF Models
FCF DCF £0.2800 £0.4400 £0.8000 77
Owner Earnings £0.1600 £0.2900 £0.5100 74
5Y Revenue Exit £0.1500 £0.2200 £0.3300 72
5Y EBITDA Exit £0.2200 £0.3800 £0.6100 73
5Y P/E Exit £0.1800 £0.2900 £0.4300 70
10Y Revenue Exit £0.1900 £0.2900 £0.4100 67
10Y EBITDA Exit £0.2400 £0.4000 £0.6600 67
10Y P/E Exit £0.2100 £0.3300 £0.5100 63
Earnings-Based
Graham-Dodd £0.0400 £0.2500 £0.3500 63
Lynch FV £0.0700 £0.1000 £0.1300 61
PEG = 1.0 £0.0700 £0.1000 £0.1300 57
EPV £0.0500 £0.0500 £0.0600 74
Multiples
P/E Multiple £0.1200 £0.1600 £0.2000 63
P/S Multiple £0.0700 £0.1000 £0.1200 58
P/B Multiple £0.0700 £0.1000 £0.1200 55
EV/EBIT £0.1300 £0.1700 £0.2200 66
EV/EBITDA £0.1900 £0.2600 £0.3200 67
EV/Revenue £0.0700 £0.1000 £0.1200 54
Asset-Based
NCAV (Graham) £0.0400 £0.0500 £0.0800 53
Growth DCF
Growth DCF £0.2700 £0.4600 £0.7500 76
Rev-Margin DCF £0.1400 £0.2100 £0.3100 72
Economic Profit
Residual Income £0.0600 £0.0600 £0.0600 71
ROIC Compounder £0.0500 £0.0500 £0.0600 72
Growth Earnings
Growth-Adj P/E £0.1200 £0.1700 £0.2200 68

Open the full fair value analysis →

Notify me when KMK reaches fair value

Put KMK on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 68/100

Of which business quality 65 · Market factors (momentum, volatility) 23

Profitability 45
Margins and returns on capital today
Quality Growth 100
Are margins and returns improving?
Cashflow 100
Earnings quality: real cash, not paper profit
Fin. Strength 53
Balance sheet, leverage, solvency risk
Investment 95
Disciplined investing over empire-building
Low Volatility 18
Calm price path (market factor)
Momentum 29
Price trend over the last 3–12 months (market factor)
52W Momentum 19
Distance to the 52-week high (market factor)
Net Issuance 0
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+36.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+30.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.1%
Start year 2020 (pandemic). Over 10 years: +12.6% a year
Revenue growth 14 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+20.9%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−41.1% (2020) → 17.7% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
not computed

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−18.4%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (UK: IMF forecast 2.3% a year to 2030, 3.3% from 2016 to 2025) that is about −20.3% a year for the price.

Watch KMK, get fair value alerts →

Compare Kromek Group PLC with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Scientific & Technical Instruments · 159 stocks

Beats the industry median on 13/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 68 · Top 25%
Fair Value upside +105% · Top 25%
Profitability
Return on equity (TTM) 25% · Top 25%
Return on assets 12% · Top 25%
Net margin (TTM) 33% · Top 25%
Operating margin (TTM) 21% · Top 25%
Growth and dividend
Revenue growth 308% · Top 25%
Balance sheet
Debt / equity 0.01× · Below median

Valuation Multiplesvs Scientific & Technical Instruments median · lower = cheaper

P/E (TTM) 3.3× · Cheapest 25%
P/B 1.34× · Cheaper than median
P/S (TTM) 1.85× · Cheaper than median
P/FCF 4.5× · Cheaper than median
EV/EBITDA 4.1× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 0
FUTURE (revenue growth)100 · sector 25
PAST (return on equity)100 · sector 24
HEALTH (low debt)100 · sector 98
DIVIDEND (yield)0 · sector 19

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Scientific & Technical Instruments stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Keysight Technologies, Inc KEYS $347.32 $115.39 −67%
Garmin Ltd GRMN $284.67 $304.44 +7%
Teledyne Technologies Incorporated TDY $621.05 $683.16 +10%
Chroma ATE Inc 2360 2,295 TWD 618.78 TWD −73%
MKS Inc MKSI $260.37 $201.24 −23%
AVIC Chengdu Aircraft Company 302132 ¥59.95 ¥19.61 −67%
Fortive Corporation FTV $55.95 $34.86 −38%
Trimble Inc TRMB $59.30 $29.11 −51%
Cognex Corporation CGNX $58.19 $38.50 −34%
Wuhan Guide Infrared Co 002414 ¥12.23 ¥9.52 −22%

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Kromek Group PLC · Fair Value
£0.1333 +51%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "Kromek Group PLC Fair Value". https://www.fairvalue-calculator.com/stock/KMK

Frequently asked questions

Is Kromek Group PLC (KMK) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of £0.1333 versus a price of £0.0650, about +105% upside (undervalued).
What is the fair value of KMK?
Our model-based fair value for Kromek Group PLC is £0.1333 (as of Sep 23, 2026), built from audited fundamentals. The current price: £0.0650.
What is the quality score of KMK?
Kromek Group PLC has a Quality Score of 68/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Kromek Group PLC (KMK)?
Our model-based price target is the fair value of £0.1333 (as of Sep 23, 2026) from 24 valuation models. Cautious scenario £0.1008, optimistic scenario £0.1658. It is a calculation from audited fundamentals, not an analyst target.
What is the Kromek Group PLC stock forecast for 2026?
Our models put fair value at £0.1333, about +105% upside versus a price of £0.0650 (undervalued). Cautious scenario £0.1008, optimistic scenario £0.1658. The calculation is refreshed regularly with new filings.
What is the revenue of Kromek Group PLC (KMK)?
Kromek Group PLC reported trailing-twelve-month revenue of about £37.8M (latest available figure, as of Sep 23, 2026).
What growth is priced into Kromek Group PLC (KMK)?
For today's price to be fair in a discounted-cash-flow model, Kromek Group PLC would have to grow free cash flow by -18.4 % per year for five years (discount rate 14.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +15.1 % per year. As of Sep 23, 2026.
What discount rate (WACC) does the fair value of KMK use?
Our models discount Kromek Group PLC at 14.4 %: a base by market capitalisation (micro), damped by beta 1.34, country premium for United Kingdom. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Kromek Group PLC that is -18.4 % per year a year over ten years, using the same discount rate (14.4 %) and the same formula as our fair value.
How much growth has Kromek Group PLC (KMK) delivered so far?
Over the past 5 years revenue at Kromek Group PLC grew +15.1 % a year. The price currently implies -18.4 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Kromek Group PLC (KMK) growing?
The median revenue growth in the sector is +8.2 % a year. That is the yardstick for the growth priced into Kromek Group PLC (-18.4 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Kromek Group PLC (KMK)?
The free-cash-flow yield on the price is 37.63 %: that much free cash flow Kromek Group PLC produces per unit of market value. When it exceeds the discount rate of our models (14.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Kromek Group PLC (KMK)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Kromek Group PLC it is £0.1333 per share (as of Sep 23, 2026), against a price of £0.0650. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Kromek Group PLC stock overvalued or undervalued in 2026?
As of Sep 23, 2026, KMK trades below its calculated fair value: price £0.0650, fair value £0.1333, a gap of about +105% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of KMK?
No. The price is what the market pays today (£0.0650); the fair value is what the company's own numbers justify (£0.1333). For Kromek Group PLC the two are £0.0683 per share apart. That gap is exactly why we show both numbers side by side.
How much is Kromek Group PLC worth?
The market values Kromek Group PLC at about 53.1M GBX (market capitalisation, as of Sep 23, 2026). Per share that is £0.0650; our models calculate a fair value of £0.1333 per share.
What do the bullish and bearish scenarios say about KMK?
Our models span a range for Kromek Group PLC: cautious scenario £0.1008, base £0.1333, optimistic £0.1658 per share (as of Sep 23, 2026, price £0.0650). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of KMK?
Kromek Group PLC trades at a price-to-earnings ratio of 3.3 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of £0.1333 is built from several models across several years. Other multiples: P/B 1.3, P/S 1.9, EV/EBITDA 4.1.
How solid is the balance sheet of Kromek Group PLC (KMK)?
Balance-sheet figures for Kromek Group PLC (as of Sep 23, 2026): return on equity 25.1%, debt of 0.01 per unit of equity. They feed the Quality Score of 68/100, which measures business quality independently of the share price.
How far is KMK from its 52-week high?
Kromek Group PLC trades at £0.0650, about 48% below its 52-week high of £0.1255 and 7% above the low of £0.0610 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of £0.1333 is for.
Which stocks are comparable to Kromek Group PLC?
From the same area (Technology) we also value Keysight Technologies, Inc, Garmin Ltd, Teledyne Technologies Incorporated, Chroma ATE Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Kromek Group PLC stock attractive at the current price?
The data as of Sep 23, 2026: price £0.0650, calculated fair value £0.1333 (+105%), Quality Score 68/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of KMK calculated?
We run Kromek Group PLC through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of £0.1333, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Kromek Group PLC currently trades 105 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Kromek Group PLC (KMK)?
The closing price on Sep 24, 2026 was £0.0650. Our model-based fair value is £0.1333, about +105% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Kromek Group PLC right now?
The price is below even our cautious bear case (£0.1008). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (68/100) at a price below fair value, the discount is the argument here, not the business quality.

Key figures of Kromek Group PLC

How large is the market capitalisation of Kromek Group PLC (KMK)?
The market capitalisation of Kromek Group PLC is 53.1M GBX. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Kromek Group PLC (KMK)?
The price-to-sales ratio of Kromek Group PLC is 0.46 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Kromek Group PLC (KMK)?
Earnings per share at Kromek Group PLC are £0.0200 (price ÷ EPS = P/E 3.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Kromek Group PLC (KMK)?
The net margin of Kromek Group PLC is 14.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Kromek Group PLC (KMK)?
The return on equity (ROE) of Kromek Group PLC is 25.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Kromek Group PLC (KMK)?
On an EBIT basis the return on assets of Kromek Group PLC is −4.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Kromek Group PLC (KMK)?
The operating margin of Kromek Group PLC is 21.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Kromek Group PLC (KMK)?
Revenue at Kromek Group PLC is growing +308% versus a year earlier (3y avg +30.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net debt does Kromek Group PLC (KMK) carry?
The net debt of Kromek Group PLC is 2.3M GBX (fiscal year 2025, ≈ 0.1 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Kromek Group PLC in the live analysis

One click puts Kromek Group PLC on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.